BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 17885521)

  • 21. Extent of myocardial scarring on nonstress delayed-contrast-enhancement cardiac magnetic resonance imaging correlates directly with degrees of resting regional dysfunction in chronic ischemic heart disease.
    Srichai MB; Schvartzman PR; Sturm B; Kasper JM; Lieber ML; White RD
    Am Heart J; 2004 Aug; 148(2):342-8. PubMed ID: 15309007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection and quantification of myocardial fibrosis in hypertrophic cardiomyopathy by contrast-enhanced cardiovascular magnetic resonance].
    Pujadas S; Carreras F; Arrastio X; Leta R; Vila M; Subirana MT; Bayés-Genís A; Pons-Lladó G
    Rev Esp Cardiol; 2007 Jan; 60(1):10-4. PubMed ID: 17288950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular magnetic resonance findings in typical versus atypical forms of the acute apical ballooning syndrome (Takotsubo cardiomyopathy).
    Haghi D; Fluechter S; Suselbeck T; Kaden JJ; Borggrefe M; Papavassiliu T
    Int J Cardiol; 2007 Aug; 120(2):205-11. PubMed ID: 17175045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative tissue characterization of infarct core and border zone in patients with ischemic cardiomyopathy by magnetic resonance is associated with future cardiovascular events.
    Heidary S; Patel H; Chung J; Yokota H; Gupta SN; Bennett MV; Katikireddy C; Nguyen P; Pauly JM; Terashima M; McConnell MV; Yang PC
    J Am Coll Cardiol; 2010 Jun; 55(24):2762-8. PubMed ID: 20538171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging.
    Cummings KW; Bhalla S; Javidan-Nejad C; Bierhals AJ; Gutierrez FR; Woodard PK
    Radiographics; 2009; 29(1):89-103. PubMed ID: 19168838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed enhancement MR imaging: utility in myocardial assessment.
    Vogel-Claussen J; Rochitte CE; Wu KC; Kamel IR; Foo TK; Lima JA; Bluemke DA
    Radiographics; 2006; 26(3):795-810. PubMed ID: 16702455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed enhancement cardiovascular magnetic resonance as a novel technique to predict cardiac events in dilated cardiomyopathy patients.
    Shimizu I; Iguchi N; Watanabe H; Umemura J; Tobaru T; Asano R; Misu K; Nagayama M; Aikawa M; Funabashi N; Komuro I; Sumiyoshi T
    Int J Cardiol; 2010 Jul; 142(3):224-9. PubMed ID: 19185371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonstress delayed-enhancement magnetic resonance imaging of the myocardium predicts improvement of function after revascularization for chronic ischemic heart disease with left ventricular dysfunction.
    Schvartzman PR; Srichai MB; Grimm RA; Obuchowski NA; Hammer DF; McCarthy PM; Kasper JM; White RD
    Am Heart J; 2003 Sep; 146(3):535-41. PubMed ID: 12947375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [MR imaging in cardiomyopathies].
    Miller S; Riessen R
    Rofo; 2005 Nov; 177(11):1497-505. PubMed ID: 16302130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU; Reiser MF; Huber AM
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.
    Mahrholdt H; Wagner A; Judd RM; Sechtem U; Kim RJ
    Eur Heart J; 2005 Aug; 26(15):1461-74. PubMed ID: 15831557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late gadolinium-enhanced cardiovascular magnetic resonance identifies patients with standardized definition of ischemic cardiomyopathy: a single centre experience.
    Soriano CJ; Ridocci F; Estornell J; Pérez-Boscá JL; Pomar F; Trigo A; Planas A; Nadal M; Jacas V; Martinez V; Paya R
    Int J Cardiol; 2007 Mar; 116(2):167-73. PubMed ID: 16828180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extent of myocardial hyperenhancement on late gadolinium-enhanced cardiovascular magnetic resonance correlates with q waves in hypertrophic cardiomyopathy.
    Papavassiliu T; Flüchter S; Haghi D; Süselbeck T; Wolpert C; Dinter D; Kühl H; Borggrefe M
    J Cardiovasc Magn Reson; 2007; 9(3):595-603. PubMed ID: 17365241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute hyperenhancement on delayed contrast-enhanced magnetic resonance imaging is the characteristic sign after coronary microembolization.
    Ma JY; Qian JY; Jin H; Chen ZW; Chang SF; Yang S; Sun AJ; Zeng MS; Zou YZ; Ge JB
    Chin Med J (Engl); 2009 Mar; 122(6):687-91. PubMed ID: 19323935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is postsystolic shortening a marker of viability in chronic left ventricular ischemic dysfunction? Comparison with late enhancement contrast magnetic resonance imaging.
    Lim P; Pasquet A; Gerber B; D'Hondt AM; Vancraeynest D; Guéret P; Vanoverschelde JL
    J Am Soc Echocardiogr; 2008 May; 21(5):452-7. PubMed ID: 18029142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed-enhancement magnetic resonance imaging in patients with clinically suspected stress cardiomyopathy (Tako-tsubo).
    Muellerleile K; Lund G; Groth M; Barmeyer A; Sultan A; Heitzer T; Willems S; Adam G; Meinertz T; Koester R
    Rofo; 2010 Jan; 182(1):29-35. PubMed ID: 19676014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do mechanical markers of myocardial ischaemia predict the transmural extent of myocardial infarction in man?
    Pingitore A; Rovai D; Positano V; Di Bella G; Strata E; De Marchi D; Passera M; Aquaro GD; Lombardi M
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):400-5. PubMed ID: 16721201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries.
    Assomull RG; Lyne JC; Keenan N; Gulati A; Bunce NH; Davies SW; Pennell DJ; Prasad SK
    Eur Heart J; 2007 May; 28(10):1242-9. PubMed ID: 17478458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic importance of late gadolinium enhancement cardiovascular magnetic resonance in cardiomyopathy.
    Ismail TF; Prasad SK; Pennell DJ
    Heart; 2012 Mar; 98(6):438-42. PubMed ID: 22128204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.